| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.6M | +56.2% |
| SG&A Expense | $5.9M | +28.1% |
| Operating Income | -$9.5M | -37.4% |
| Interest Expense | $17K | -99.0% |
| Income Tax | $0 | — |
| Net Income | -$9.3M | -10.0% |
| EPS (Basic) | -$7.14 | -852.0% |
| EPS (Diluted) | -$7.14 | +61.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.9M | +68.0% |
| Current Assets | $10.9M | +63.7% |
| Total Assets | $10.9M | +63.7% |
| Current Liabilities | $1.8M | +58.5% |
| Total Liabilities | $1.8M | +58.5% |
| Stockholders' Equity | $9.1M | +64.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | -11.3% |
| Financing Cash Flow | $11.7M | -10.3% |